treatment of PROM1-associated retinal dystrophy
All entries for: Langxin Qisheng (Suzhou) Biopharmaceutical Co. Ltd.
June 8, 2026
Langxin Qisheng (Suzhou) Biopharmaceutical Co. Ltd.
Orphan Drug Designation
Disease Area: Rare Diseases